Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Free Cash Flow (2010 - 2022)

Grifols' (GIFLF) quarterly Free Cash Flow came in at -$1.5 million in Q4 2022, down 101.25% quarter-over-quarter from $116.3 million in Q1 2020.

Analysis

Grifols (GIFLF) Free Cash Flow (2010 - 2022) Analysis & Trends

Grifols (GIFLF) has reported Free Cash Flow for 12 consecutive years, with -$1.5 million the latest figure, recorded in Q4 2022.

  • For the quarter ending Q4 2022, Free Cash Flow changed N/A year-over-year to -$1.5 million; the trailing twelve-month figure through Dec 2022 stood at $299.7 million (changed N/A YoY), and the FY2025 full-year result was $883.5 million, up 23.59% from the prior year.
  • Free Cash Flow fell to -$1.5 million in Q4 2022 per GIFLF's latest filing, from $116.3 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $466.5 million in Q4 2018 and bottomed at -$190.6 million in Q1 2019.
  • Historically, Free Cash Flow has averaged $152.4 million across 4 years, with a median of $116.3 million in 2020.
  • The sharpest annual moves came in 2019 and 2020: Free Cash Flow sank 267.38% in 2019, then soared 161.02% in 2020.
  • Over 4 years, Free Cash Flow stood at $466.5 million in 2018, then dropped by 19.52% to $375.5 million in 2019, then sank by 69.02% to $116.3 million in 2020, then plunged by 101.25% to -$1.5 million in 2022.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$1.5 million, $116.3 million, and $375.5 million for Q4 2022, Q1 2020, and Q4 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 3.49 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 3.43 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 1.01 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 572.80 Mn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -563.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn 292.04 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 408.00 Mn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -268.64 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -1.46 Mn
Mar 31, 2020 116.32 Mn
Dec 31, 2019 375.47 Mn
Mar 31, 2019 -190.63 Mn
Dec 31, 2018 466.54 Mn
Jun 30, 2018 186.75 Mn
Mar 31, 2018 113.89 Mn
Dec 31, 2017 671.81 Mn
Jun 30, 2017 256.39 Mn
Mar 31, 2017 154.89 Mn
Dec 31, 2016 194.78 Mn
Sep 30, 2016 229.95 Mn
Dec 31, 2015 340.22 Mn
Sep 30, 2015 194.93 Mn
Jun 30, 2015 246.47 Mn
Mar 31, 2015 38.56 Mn
Dec 31, 2014 403.75 Mn
Sep 30, 2014 870.02 Mn
Jun 30, 2014 -170.75 Mn
Mar 31, 2014 171.11 Mn